We are pleased to announce that Galmed Pharmaceuticals Ltd. (NasdaqCM:GLMD) entered into a sales agreement relating to the shares of the Company’s common stock offered from time to time in sales deemed to be “at the market offerings.” Jones is the Sole Sales Agent for this offering. For any inquiries related to this transaction, please contact our Equity Capital Markets group at [email protected] Read More: https://lnkd.in/eHKChBJV
关于我们
JonesTrading is one of the oldest and largest executing equity trading firms in the U.S. and is a worldwide leader in equity block trading. Since 1975, the sole focus of JonesTrading has been creating liquidity for institutional and corporate clients on an unconflicted basis. The ability to provide a secure, trusted platform connecting a diverse group of market players enables the firm to unlock liquidity, providing best-quality execution for larger and more complex trades. JonesTrading has been a trusted, high touch execution partner for institutional money managers and hedge funds for over 40 years. We understand the intricacies of execution and the importance of anonymity. Through our network of over 100 registered representatives we source liquidity from over 1,500 institutions and hedge funds in addition to virtually every exchange and dark pool. We are able to secure advantageous prices across the greatest number of markets in a timely manner, without revealing client intent. We remain neutral and clients remain anonymous, minimizing market impact and opportunity costs. Refer to the Firm's website ("Our Companies") for relevant disclosures: https://www.jonestrading.com/
- 网站
-
https://www.JonesTrading.com
JonesTrading的外部链接
- 所属行业
- 金融服务
- 规模
- 51-200 人
- 总部
- Thousand Oaks ，California
- 类型
- 私人持股
- 创立
- 1975
地点
JonesTrading员工
动态
-
We are pleased to announce that AG Mortgage Investment Trust, Inc. (NYSE:MITT) entered into a sales agreement relating to the shares of the Company’s common stock offered from time to time in sales deemed to be “at the market offerings.” Jones is a Sales Agent for this offering. For any inquiries related to this transaction, please contact our Equity Capital Markets group at [email protected] Read More:?https://lnkd.in/eAT2uRqT
-
-
Jones is pleased to have served as a financial advisor on KalVista Pharmaceuticals, Inc.'s (NasdaqGM:KALV) $55 million follow-on offering. For any inquiries related to this transaction, please contact our Equity Capital Markets group at [email protected] Read More: https://lnkd.in/eCv6cHt5
-
-
With Election Day tomorrow, Jones is excited to share the “Election Edition” of our Healthcare Pulse monthly newsletter. In this special edition, you will find a comprehensive analysis of each presidential election since 2004 including: key issues, major healthcare themes, polling trends, market reactions, and more. ? While no election is the same, we believe this detailed look at our past helps inform a better understanding of the present and provides insight into the key trends we see today. ? Please reach out to your Jones representative for more information or a copy of the newsletter.?
-
-
Jones is pleased to have served as sole book-running manager on CalciMedica, Inc.'s (NasdaqCM:CALC) $10.2 million follow-on offering. For any inquiries related to this transaction, please contact our Equity Capital Markets group at [email protected] Read More: https://lnkd.in/eu6wDXEU
-
-
Join JonesResearch for our Virtual Genetic Medicine Day on November 25th, 2024 ? Connect with industry pioneers and thought leaders through expert panels and intimate fireside chats exploring the future of genetic medicine. ? Featured Participants: - Management teams from leading public companies covered by JonesResearch, including EDIT, NTLA, PRME, DTIL, WVE, KRRO, and RGLS - Executive leadership from emerging innovators such as Ensoma and iECURE ? If you are interested in gaining valuable insights into the evolving genetic medicine landscape, please email [email protected]
-
-
Jones is pleased to have served as an underwriter on EyePoint Pharmaceuticals, Inc.'s (NasdaqGM:EYPT) $140 million follow-on offering. For any inquiries related to this transaction, please contact our Equity Capital Markets group at [email protected] Read More: https://lnkd.in/edtVixwN
-
-
JonesResearch will be hosting a virtual KOL event with Dr. Marijana Tadic, MD, PhD, Associate Professor, Cardiology at the Charité in Berlin, Germany. The call will take place Tuesday, October 22nd, at 1:00 PM ET to discuss recent data from Wave Life Sciences' (NasdaqGM:WVE) upcoming DMD catalysts, key clinical outcomes in DMD, and the European regulatory perspective on DMD endpoints. Please use the following link for registration: https://lnkd.in/eaJdt9qv
-
-
We are pleased to announce that Western Asset Mortgage Opportunity Fund Inc. (NYSE:DMO) entered into a sales agreement relating to the shares of the Company’s common stock offered from time to time in sales deemed to be “at the market offerings.” Jones is the Sole Sales Agent for this offering. For any inquiries related to this transaction, please contact our Equity Capital Markets group at [email protected] Read More: https://lnkd.in/eBmUgFW7
-